Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
BMC Cancer|June 11, 2010
Periostin is up-regulated in high grade and high stage prostate cancerVerena Tischler, Florian R Fritzsche, Peter J Wild, et al.
Oncotarget|January 14, 2016
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patientsTatsuo Sugawara, Pascale Lejeune, Silke Köhr, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2014
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxiaSebastian Meller, Anne Bicker, Matteo Montani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosisDavid A Brown, Carsten Stephan, Robyn L Ward, et al.
European Urology|August 21, 2014
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective StudyNicola Fossati, Nicolò Maria Buffi, Alexander Haese, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
The Journal of Urology|August 23, 2017
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic RoleSophia Spatz, Yuri Tolkach, Klaus Jung, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Biological Chemistry|June 28, 2006
A comprehensive nomenclature for serine proteases with homology to tissue kallikreinsAke Lundwall, Vimla Band, Michael Blaber, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
BMC Cancer|June 11, 2010
Periostin is up-regulated in high grade and high stage prostate cancerVerena Tischler, Florian R Fritzsche, Peter J Wild, et al.
Oncotarget|January 14, 2016
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patientsTatsuo Sugawara, Pascale Lejeune, Silke Köhr, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2014
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxiaSebastian Meller, Anne Bicker, Matteo Montani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosisDavid A Brown, Carsten Stephan, Robyn L Ward, et al.
European Urology|August 21, 2014
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective StudyNicola Fossati, Nicolò Maria Buffi, Alexander Haese, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
The Journal of Urology|August 23, 2017
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic RoleSophia Spatz, Yuri Tolkach, Klaus Jung, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Biological Chemistry|June 28, 2006
A comprehensive nomenclature for serine proteases with homology to tissue kallikreinsAke Lundwall, Vimla Band, Michael Blaber, et al.
Pageof 23